Paroxetine versus placebo for depressive disorders

A pairwise meta-analysis of 4 trials comparing paroxetine with placebo for depressive disorders in children and adolescents. The analysed binary outcome is remission or response as defined in the trials.

Usage

data(pma.hetrick2012)

Format

A data frame with 4 rows of arm-based data and 9 columns.

Source

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN. Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2012;11(11):CD004851. doi: 10.1002/14651858.CD004851.pub3

Details

The interventions have been coded as follows: 1, placebo; 2, paroxetine.